Evidence map›Paper›PMID 40128490›Full record

ReviewCurrent diabetes reports2025

Neonatal and Syndromic Forms of Diabetes.

McKinlee R S Gobble, Stephen I Stone

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Current diabetes reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

McKinlee R S GobbleDepartment of Pediatrics, Division of Endocrinology and Diabetes, Washington University School of Medicine, St. Louis, MO, 63110, U.S.A.ORCID http://orcid.org/0009-0007-6745-1382
Stephen I StoneDepartment of Pediatrics, Division of Endocrinology and Diabetes, Washington University School of Medicine, St. Louis, MO, 63110, U.S.A.. sstone@wustl.edu.ORCID http://orcid.org/0000-0002-6128-9341

Funding

Using a Rare Disease Model to Explore the Role of FGF21 in Insulin ResistanceK08DK124574 · NIDDK · WASHINGTON UNIVERSITY · PI Stephen Isaac Stone · 2023 to 2024
$322k
NIDDK NIH HHS K08 DK124574NIH HHS DK124574
6 · The paper itself

Abstract

purpose of reviewNeonatal and syndromic diabetes are rare but important conditions. These conditions often result in severe insulin deficiency or insulin resistance. In this review, we aim to discuss the clinical characteristics and genetics of neonatal and syndromic forms of diabetes. RECENT

findingsBeyond the development of diabetes mellitus, many other organ systems are affected. Understanding the pathophysiology of these conditions have improved our collective understanding of the genetics and developmental biology related to glucose metabolism and beyond. This review will provide new information for researchers and provide a helpful resource for clinicians when evaluating a patient for neonatal and syndromic forms of diabetes.

Indexed as

Diabetes MellitusHumansInfant, NewbornInfant, Newborn, DiseasesInsulin ResistanceSyndromeDiabetesGeneticsNeonatal diabetesSyndromic diabetes

Identifiers

PMID40128490
PMCPMC11933229

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.